<DOC>
	<DOCNO>NCT01237028</DOCNO>
	<brief_summary>This study help show efficacy vitamin D address optimal strategy minimize renal injury IgAN patient .</brief_summary>
	<brief_title>Additive Renoprotective Effects Oral Calcitriol IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Biopsyproven Ig AN patient aged 2070 year Patients residual proteinuria &gt; 500 mg/g creatinine despite reninangiotensin system blockade adequate blood pressure control 3 month Patients give inform consent , 4 ) estimate GFR &gt; = 30 ml/min/1.73 m2 . patient &lt; 20 year &gt; 70 year hypersensitivity vitamin D analog patient need urgent dialysis hypercalcemia within 3 month ( uncorrected serum calcium level &gt; 10.2 mg/dL ) clinical feature rapidly progressive glomerulonephritis life expectancy le 24 month uncontrolled hypertension decompensated liver lung disease symptomatic heart failure ( NYHA class IIIV LVEF &lt; 40 % ) estimate GFR &lt; 30 ml/min/1.73 m2 .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>